|
6/14/2013 6:30:56 AM
|
Uroplasty To Delay Filing Of Its Annual Report On Form 10-K
|
|
5/30/2013 4:18:09 PM
|
Uroplasty Q4 Loss Per Share $0.05 Vs Loss $0.03 Last Year
|
|
5/30/2013 3:03:52 PM
|
|
|
5/10/2013 7:04:24 AM
|
Uroplasty: STEP Study 3-Yr Results Demonstrate Sustained Therapeutic Effects Of Percutaneous Tibial Nerve Stimulation
|
|
4/5/2013 9:17:49 AM
|
|
|
4/5/2013 9:03:30 AM
|
Uroplasty Says David Kaysen Tendered Resignation As President, CEO
|
|
3/18/2013 10:31:11 AM
|
|
|
2/5/2013 4:48:14 PM
|
Uroplasty Names Darin Hammers VP, US Sales
|
|
1/24/2013 4:46:01 PM
|
Uroplasty Posts Q3 Loss Per Share Of $0.03 Vs. Loss $0.05 Year Ago
|
|
12/13/2012 12:02:47 PM
|
|
|
12/6/2012 7:47:59 AM
|
|
|
12/6/2012 7:04:33 AM
|
Uroplasty Announces Study Results Comparing Cost Effectiveness Of Neuromodulation Therapies For OAB Patients
|
|
11/27/2012 7:11:27 AM
|
Uroplasty Announces Significant New Coverage Decisions By Private Payers And Medicare
|
|
11/14/2012 10:00:24 AM
|
|
|
11/13/2012 3:00:30 PM
|
|
|
10/25/2012 4:46:08 PM
|
Uroplasty Posts Q2 Loss Per Share Of $0.03 Vs. Loss $0.06 Year Ago
|
|
10/25/2012 3:01:22 PM
|
|
|
10/15/2012 7:58:15 AM
|
Uroplasty Announces Implanted Tibial Nerve Stimulator Long-Term Study Presentation At ICS
|
|
7/26/2012 5:12:06 PM
|
Uroplasty Posts Q1 Loss Per Share Of $0.05 Vs. Loss $0.06 Year Ago
|
|
7/26/2012 3:00:32 PM
|
|